Coevolution of bacteriophage PP01 and Escherichia coli O157:H7 in continuous culture

被引:141
作者
Mizoguchi, K [1 ]
Morita, M [1 ]
Fischer, CR [1 ]
Yoichi, M [1 ]
Tanji, Y [1 ]
Unno, H [1 ]
机构
[1] Tokyo Inst Technol, Dept Bioengn, Midori Ku, Yokohama, Kanagawa 2268501, Japan
关键词
D O I
10.1128/AEM.69.1.170-176.2003
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The interaction between Escherichia coli O157:H7 and its specific bacteriophage PP01 was investigated in chemostat continuous culture. Following the addition of bacteriophage PP01, E. coli O157:H7 cell lysis was observed by over 4 orders of magnitude at a dilution rate of 0.876 h(-1) and by 3 orders of magnitude at a lower dilution rate (0.327 h(-1)). However, the appearance of a series of phage-resistant E. coli isolates, which showed a low efficiency of plating against bacteriophage PP01, led to an increase in the cell concentration in the culture. The colony shape, outer membrane protein expression, and lipopolysaccharide production of each escape mutant were compared. Cessation of major outer membrane protein OmpC production and alteration of lipopolysaccharide composition enabled E. coli O157:H7 to escape PP01 infection. One of the escape mutants of E. coli O157:H7 which formed a mucoid colony (Mu) on Luria-Bertani agar appeared 56 h postincubation at a dilution rate of 0.867 h(-1) and persisted until the end of the experiment (similar to200 h). Mu mutant cells could coexist with bacteriophage PP01 in batch culture. Concentrations of the Mu cells and bacteriophage PP01 increased together. The appearance of mutant phage, which showed a different host range among the O157:H7 escape mutants than wild-type PP01, was also detected in the chemostat culture. Thus, coevolution of phage and E. coli O157:H7 proceeded as a mutual arms race in chemostat continuous culture.
引用
收藏
页码:170 / 176
页数:7
相关论文
共 27 条
[1]   Bacteriophages show promise as antimicrobial agents [J].
Alisky, J ;
Iczkowski, K ;
Rapoport, A ;
Troitsky, N .
JOURNAL OF INFECTION, 1998, 36 (01) :5-15
[2]   Use of lytic bacteriophage for control of experimental Escherichia coli septicemia and meningitis in chickens and calves [J].
Barrow, P ;
Lovell, M ;
Berchieri, A .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1998, 5 (03) :294-298
[3]   Bacteriophage therapy and prophylaxis: Rediscovery and renewed assessment of potential [J].
Barrow, PA ;
Soothill, JS .
TRENDS IN MICROBIOLOGY, 1997, 5 (07) :268-271
[4]   Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin-resistant Enterococcus faecium [J].
Biswas, B ;
Adhya, S ;
Washart, P ;
Paul, B ;
Trostel, AN ;
Powell, B ;
Carlton, R ;
Merril, CR .
INFECTION AND IMMUNITY, 2002, 70 (01) :204-210
[5]  
Bohannan BJM, 1997, ECOLOGY, V78, P2303
[6]  
Carlton Richard M., 1999, Archivum Immunologiae et Therapiae Experimentalis, V47, P267
[7]   Pathogenicity of Escherichia coli O157:H7 in the intestines of neonatal calves [J].
DeanNystrom, EA ;
Bosworth, BT ;
Cray, WC ;
Moon, HW .
INFECTION AND IMMUNITY, 1997, 65 (05) :1842-1848
[8]   BACTERIOPHAGE DISTRIBUTION IN HUMAN FECES - CONTINUOUS SURVEY OF HEALTHY-SUBJECTS AND PATIENTS WITH INTERNAL AND LEUKEMIC DISEASES [J].
FURUSE, K ;
OSAWA, S ;
KAWASHIRO, J ;
TANAKA, R ;
OZAWA, A ;
SAWAMURA, S ;
YANAGAWA, Y ;
NAGAO, T ;
WATANABE, I .
JOURNAL OF GENERAL VIROLOGY, 1983, 64 (SEP) :2039-2043
[9]   Bacteriophage T4 development depends on the physiology of its host Escherichia coli [J].
Hadas, H ;
Einav, M ;
Fishov, I ;
Zaritsky, A .
MICROBIOLOGY-UK, 1997, 143 :179-185
[10]  
Hancock D.D., 1998, Escherichia coli O157:H7 and Other Shiga Toxin-Producing E. coli Strains, P85, DOI [10.3168/jds.S0022-0302(05)73131-3., DOI 10.3168/JDS.S0022-0302(05)73131-3]